Of the 37 million patients in the U.S. with Type 2 diabetes, about half of them suffer from peripheral neuropathy, according to National Institutes of Health estimates. The condition causes numbness, ...

MONTREAL —Tirzepatide (Mounjaro, Eli Lilly), the dual gastric inhibitory polypeptide–glucagon-like peptide 1 (GIP–GLP-1) receptor agonist that has shown significant benefits in diabetes and obesity, ...

While the immediate goal of bariatric surgery is to help obese patients shed significant weight, new research shows it may also reduce diabetes complications, including nerve damage. Investigators ...

After the initial screening history, physical examination, and laboratory assessment, 148 subjects were identified who were potentially eligible and underwent full cardiac evaluation. Twelve subjects ...

Last patient last visit (LPLV) was reached for the 127 adult and elderly patients enrolled into the 12-week placebo-controlled trial with nispomeben (NRD.E1) Topline results are expected in November ...